(Q35136114)

PubMed publication ID

6 August 2017

1 reference

title

Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

1 reference

1 reference

A M Katz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

publication date

1 January 2003

1 reference

PubMed publication ID

12767256

Journal of Cellular and Molecular Medicine

6 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Inotropic therapy for heart failure: an evidence-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle--Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Ernest Henry Starling, his predecessors, and the "Law of the Heart"

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

The importance of the shape and size of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Ventricular remodeling in myocardial infarction--the rat and the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00197.X

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

21 January 2018

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction

1 reference

12 December 2020

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

1 reference

12 December 2020

Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes

1 reference

12 December 2020

Crossovers between functional and proliferative signaling: key to understanding the pathophysiology and management of heart failure

1 reference

12 December 2020

Wall stress and patterns of hypertrophy in the human left ventricle

1 reference

12 December 2020

Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction

1 reference

12 December 2020

Action of digitalis on the nonfailing heart of the dog.

1 reference

12 December 2020

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

LEFT VENTRICULAR TENSION AND STRESS IN MAN

1 reference

12 December 2020

On the mechanism of compensatory hyperfunction and insufficiency of the heart

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Certain mechanical peculiarities of the human cardiac pump in normal and diseased states

1 reference

12 December 2020

Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.

1 reference

12 December 2020

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition

1 reference

12 December 2020

Congestive heart failure: role of altered myocardial cellular control

1 reference

12 December 2020

Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction

1 reference

12 December 2020

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

12 December 2020

Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure

1 reference

12 December 2020

Potential deleterious effects of inotropic agents in the therapy of chronic heart failure

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

12 December 2020

Global cardiac remodeling after acute myocardial infarction: a study in the rat model

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Survival in congestive heart failure during treatment with drugs with positive inotropic actions.

1 reference

12 December 2020

Wall stress in the normal and hypertrophied human left ventricle.

1 reference

12 December 2020

Contractile State of Cardiac Muscle Obtained from Cats with Experimentally Produced Ventricular Hypertrophy and Heart Failure

1 reference

12 December 2020

Evolution and the cardiac patient

1 reference

12 December 2020

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

12 December 2020

Expansion of acute myocardial infarction: an experimental study

1 reference

12 December 2020

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

12 December 2020

A new inotropic drug: its promise and a caution

1 reference

12 December 2020

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage

1 reference

12 December 2020

Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators

1 reference

12 December 2020

The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.

1 reference

12 December 2020

Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial

1 reference

12 December 2020

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

12 December 2020

10.1111/J.1582-4934.2003.TB00197.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740240&resulttype=core&format=json

12 May 2020

PubMed publication ID

12767256

1 reference